New patient adherence tablet app incorporates storytelling and patient data.

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

DMS could make early drug discovery cheaper, faster and more efficient.

Marathon sells Emflaza, but questions remain about FDA approval processes.

Could compound derived from tick saliva make effective pharmaceuticals?

Can genetically engineered bacteria help alleviate cold chain issues for oral vaccines?

Outsourced manufacturing is set to grow by 6.6 percent over the next four years.

FDA and EMA forge an agreement to mutually recognize drug manufacturing inspections.

Can noise-induced hearing loss be treated by regenerating inner ear hair cells.

A campaign to counter criticism and a first foray into biosimilars… What’s new in business?